Stay updated on Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.

Latest updates to the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page
- Check2 days agoChange DetectedNew history entries were added on 2025-12-24 for Contacts/Locations and Study Status. An entry dated 2025-09-30 was removed.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded: Revision: v3.3.3; Removed: HHS Vulnerability Disclosure; Removed: Revision: v3.3.2. These are minor site-wide changes that do not affect core content or user tasks; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page history now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check45 days agoChange DetectedThe government funding/operating-status notice was removed from the page. No trial-related content changed.SummaryDifference0.2%

- Check59 days agoChange DetectedIPDSharing was added to the study record; multiple versions updated Study Status and Contacts/Locations.SummaryDifference0.0%

- Check88 days agoChange DetectedPage content updated: new funding-status notice and updated 2025 dates with a new revision (v3.2.0) replacing v3.1.0; older date and revision removed.SummaryDifference7%

Stay in the know with updates to Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.